postmenopausal [tmco]
Estradiol [horm, phsu, strd]
Dydrogesterone [horm, phsu, strd]
therapy [ftcn]
Affect [menp]
Fibrinolysis [phsf]
Lp(a) [aapp, bacs]
Health [idcn]
Women [popg]
Impaired [ftcn]
Fibrinolysis [phsf]
Increased lipoprotein [fndg]
Lp(a) [aapp, bacs]
Elements [elii]
pathogenesis [ftcn]
Events [evnt]
Study [mnob]
investigate [ftcn]
Long-Term Effects [phpr]
Estradiol [horm, phsu, strd]
Dydrogesterone [horm, phsu, strd]
therapy [ftcn]
Fibrinolysis [phsf]
Lipoprotein (a) [aapp, bacs]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
Women [popg]
randomized [resa]
Hormone replacement therapy [topp]
Group [idcn]
N NOS [aapp, imft]
Control Group [grup]
N NOS [aapp, imft]
months [tmco]
Hormone replacement therapy [topp]
Group [idcn]
treated [topp]
Oral [spco]
17 beta-Estradiol [horm, phsu, strd]
E2 [gngm]
mg% [qnco]
Daily [tmco]
Combined [qlco]
Dydrogesterone [horm, phsu, strd]
mg% [qnco]
Daily [tmco]
days [tmco]
treatment [ftcn]
Cycle [tmco]
Women [popg]
Received [qlco]
Oral [spco]
E2 [gngm]
mg% [qnco]
Daily [tmco]
Combined [qlco]
Dydrogesterone [horm, phsu, strd]
mg% [qnco]
Daily [tmco]
days [tmco]
treatment [ftcn]
Cycle [tmco]
3 Months [tmco]
Control Group [grup]
Received [qlco]
treatment [ftcn]
baseline [bodm]
Note [clna]
Group [idcn]
Compared [acty]
Control Group [grup]
repeated measures [resa]
baseline [bodm]
Value [qnco]
months [tmco]
Hormone replacement therapy [topp]
Levels [qlco]
Plasma [bdsu]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
P NOS [aapp, imft]
Lp(a) [aapp, bacs]
P NOS [aapp, imft]
Levels [qlco]
Plasma [bdsu]
Plasmin [aapp, enzy, phsu]
Antiplasmin [aapp, bacs, phsu]
Complex [qlco]
P NOS [aapp, imft]
months [tmco]
treatment [ftcn]
mg% [qnco]
E2 [gngm]
Regimen [topp]
Plasma [bdsu]
Plasmin [aapp, enzy, phsu]
Antiplasmin [aapp, bacs, phsu]
Complex [qlco]
Compared [acty]
treatment [ftcn]
Hormone replacement therapy [topp]
Plasma [bdsu]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Thrombin-antithrombin complex [aapp, enzy]
Prothrombin fragment 1+2 [aapp, bacs]
Factor VIIa [aapp, enzy, phsu]
Conclusions [idcn]
Combined [qlco]
E2 [gngm]
Dydrogesterone [horm, phsu, strd]
fibrinolytic [topp]
Decrease [qlco]
Lp(a) [aapp, bacs]
Deterioration [phpr]
Coagulation [ortf]
Marker [clna]
Measured [qlco]
Publisher [ocdi]
LTD [ortf]
